Methyl 2-amino-3,3,3-trifluoro-2-methylpropanoate; hydrochloride, 5g

Ethyltriphenylphosphonium bromide, 98.0%, 100g

8-Bromo-6-fluoroimidazo[1,2-a]pyridine, 97%, 1g

(1-Isopropylpiperidin-4-yl)methanamine dihydrochloride, 95.0%, 250mg

p-Cymene>95.0%(GC)500mL

(4S)-N-(TERT-BUTYLDIMETHYLSILYL)AZETIDIN-2-ONE-4-CARBOXYLIC ACID, 250mg

(3R,4R)-3-Fluorotetrahydro-2H-pyran-4-amine hydrochloride, 98%, 1g

Methyl 3-hydroxycyclopentanecarboxylate, 95.0%, 1g

(3-Chloro-benzyl)-ethyl-amine, 95.0%, 5g

(2R,3R,4R,5R)-2-(6-benzamido-9H-purin-9-yl)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-((tert-butyldimethylsilyl)oxy)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite, 98%, 10g

n-(3-Ethynylphenyl)tetrahydro-2h-pyran-4-amine, 95%, 10g

Tert-butyl 2-(4-hydroxypiperidin-1-yl)acetate, 98%, 1g

(S)-2-((tert-Butoxycarbonyl)amino)-3-(2-nitrophenyl)propanoic acid, 95.0%, 5g